VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype.
- Published in:
- Molecular Carcinogenesis, 2021, v. 60, n. 7, p. 497, doi. 10.1002/mc.23307
- By:
- Publication type:
- Article
Works matching IS 0899-1987 AND VI 60 AND IP 7 AND DT 2021
Results: 7
1
2
Feed‐forward activation of STAT3 signaling limits the efficacy of c‐Met inhibitors in esophageal squamous cell carcinoma (ESCC) treatment.
- Published in:
- Molecular Carcinogenesis, 2021, v. 60, n. 7, p. 481, doi. 10.1002/mc.23306
- By:
- Publication type:
- Article
3
The LncRNA FGD5‐AS1/miR‐497‐5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin‐resistance in laryngeal squamous cell carcinoma.
- Published in:
- Molecular Carcinogenesis, 2021, v. 60, n. 7, p. 469, doi. 10.1002/mc.23305
- By:
- Publication type:
- Article
4
Thyroglobulin as a negative marker for malignancy in canine and human breast tumors.
- Published in:
- Molecular Carcinogenesis, 2021, v. 60, n. 7, p. 455, doi. 10.1002/mc.23304
- By:
- Publication type:
- Article
5
YAP/TEAD4‐induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma.
- Published in:
- Molecular Carcinogenesis, 2021, v. 60, n. 7, p. 440, doi. 10.1002/mc.23303
- By:
- Publication type:
- Article
6
Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype.
- Published in:
- Molecular Carcinogenesis, 2021, v. 60, n. 7, p. 429, doi. 10.1002/mc.23301
- By:
- Publication type:
- Article
7
Issue Information ‐ Ed Board.
- Published in:
- Molecular Carcinogenesis, 2021, v. 60, n. 7, p. 427, doi. 10.1002/mc.23222
- Publication type:
- Article